Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...

Accelerating C-level turnover: Executives, particularly those navigating complex global portfolios, are facing unprecedented ...

If a deal is confirmed and consummated, Novartis would claim ownership of a biotech that has raised something of a stir in ...

At HLTH Europe 2025 in Amsterdam, pharmaphorum Deep Dive editor Eloise McLennan sat down with Eugene Borukhovich (CEO, YourCoach Health), David Klein (CEO, Click Therapeutics), and Malin Johansson ...

In Part Two, putting theory into practice is addressed.

Researchers at the University of Arizona recently studied a non-invasive technique that uses sound waves to stimulate ...

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of ...

A jury in the US has found that tech giant Meta illegally compromised the privacy of a US woman who shared her data with a ...

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

The joint information sharing agreement between the medicines regulatory authority and reimbursement agency was first ...

US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he will cut $500 million in funding for mRNA ...

In a post-Congress conversation, web editor Nicole Raleigh spoke with Dr Corina Dutcus, senior vice president and oncology ...